Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • US Food and Drug...

    Tag: u.s. food and drug administration

    You Searched For "US Food and Drug Administration"
    USFDA cautions Aurobindo Pharmas oral solids formulation facility of regulatory action

    USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action

    MD bureau31 Jan 2020 7:59 AM
    NEW DELHI: Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing...
    USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility

    USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility

    MD bureau28 Jan 2020 8:54 AM
    New Delhi: Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of...
    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Medical Dialogues Bureau26 Nov 2019 4:00 AM
    In September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Farhat Nasim20 Nov 2019 7:14 AM
    New Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Medical Dialogues Bureau5 Nov 2019 7:27 AM
    New Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Farhat Nasim29 Oct 2019 4:30 AM
    The audit of Dr Reddy's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the...
    Shilpa Medicare Telangana facility gets EIR from USFDA

    Shilpa Medicare Telangana facility gets EIR from USFDA

    Medical Dialogues Bureau26 Oct 2019 6:16 AM
    "The USFDA has concluded that the inspection classification of Jadcherla facility was "voluntary action indicated". This facility is in an acceptable...
    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Medical Dialogues Bureau25 Oct 2019 6:02 AM
    Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Medical Dialogues Bureau22 Oct 2019 4:20 AM
    Roche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
    Sanofi pulls popular heartburn drug Zantac in US, Canada

    Sanofi pulls popular heartburn drug Zantac in US, Canada

    Medical Dialogues Bureau21 Oct 2019 4:00 AM
    In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and...
    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Medical Dialogues Bureau16 Oct 2019 10:40 AM
    "We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Medical Dialogues Bureau12 Oct 2019 6:11 AM
    The US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok